Patent ID: 9201064
Filing Date: 2015-12-01
Classification: G01N,Y10T

Abstract:
1. A non-invasive method of diagnosing a lifestyle that allows a subject to delay and/or avoid an ageing related chronic inflammatory disorder, the method comprising: determining a level of phenylacetylglutamine (PAG) in a urine sample obtained from the subject after a change in lifestyle has been made and comparing the subject's PAG level to a predetermined reference value, wherein the predetermined reference value is based on a urine PAG level obtained from the subject before the change in lifestyle, wherein the subject is a human adult of at least 45 years of age, wherein the ageing related chronic inflammatory disorder is atherosclerosis, arthritis, dementia, type 2 diabetes, or osteoporosis, and wherein an elevated urine PAG level in the sample compared to the predetermined reference value indicates an increased likelihood that the change in lifestyle allows the subject to delay and/or avoid the ageing related chronic inflammatory disorder.